Concepedia

Sabine M. Wittemer

SM

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2001

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Sabine M. Wittemer is an author at Merck KGaA, Darmstadt (Germany) specializing in pharmacy, pharmacology, and cancer pharmacology.

Publications per year

2001–2012

6

Publications

6

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

David A. Reardon, Karen Fink, Tom Mikkelsen et al. · Journal of Clinical Oncology · 2008 · 473 citations · Full text

, , +16

Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma

Burt Nabors, Tom Mikkelsen, Steven S. Rosenfeld et al. · Journal of Clinical Oncology · 2007 · 289 citations

, , +17

Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans

Sabine M. Wittemer, M. Ploch, Timo Windeck et al. · Phytomedicine · 2004 · 202 citations

, , +15

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

Kevin B. Kim, Víctor G. Prieto, Richard W. Joseph et al. · Melanoma Research · 2012 · 75 citations · Full text

, , +14

Validated method for the determination of hydroquinone in human urine by high-performance liquid chromatography–coulometric-array detection

Jörg Wittig, Sabine M. Wittemer, Markus Veit · Journal of Chromatography B Biomedical Sciences and Applications · 2001 · 60 citations

, , +6

1–5 of 6